Anti-Cancer Agents in Medicinal Chemistry brings cutting-edge advances in the discovery and development of anti-cancer agents. Focused on the intersection of medicinal chemistry and cancer biology, it offers critical insights into novel therapeutic strategies. The journal presents original research articles, reviews, and perspectives that cover all aspects of drug design, synthesis, and biological evaluation.
Coverage includes chemical synthesis, target identification, mechanism of action studies, and preclinical and clinical evaluations. The journal is indexed in databases like CAS, Scopus, and Web of Science, reaching medicinal chemists, pharmacologists, and cancer researchers. It's committed to fostering innovation in cancer drug discovery. The journal is aimed at accelerating the translation of basic research findings into clinical applications.
It encourages submissions that present novel approaches to tackling cancer, ultimately contributing to improved treatment outcomes. By uniting expertise from diverse disciplines, it plays a crucial role in advancing the fight against cancer. Anti-Cancer Agents in Medicinal Chemistry emphasizes groundbreaking research.